Edgar V.

Edgar V. is a seasoned professional in the pharmaceutical and healthcare industries, currently serving as a Rare Diseases Portfolio Leader at Amgen since 2025. With extensive experience in business development and marketing, Edgar has held significant roles including Business Development Accounts Director at Indegene and Surgery APM for the Canada Region at BD. Previous positions include Oncology Product Manager for Central America at Novartis Oncology, Oncology Associate Marketing Director at Merck, and various product management roles at Merck Group, Actelion, Abbott, and Hoffmann-La Roche. Edgar’s educational background includes an MBA from Hult Ashridge Executive Education and certificates in Digital Marketing Management from the University of Toronto, among other qualifications from prestigious institutions such as Harvard University and Instituto Tecnológico Autónomo de México.